Integer Holdings Corp SEC 10-Q Report

Integer Holdings Corp, a leading medical device outsource manufacturer, has released its Form 10-Q report for the third quarter of 2025. The report highlights the company's robust financial performance and strategic business initiatives aimed at enhancing its market position and operational capabilities.

Financial Highlights

• Sales: $467.691 million, reflecting an increase from the previous year's $431.417 million, indicating strong revenue growth.
• Gross Profit: $126.160 million, up from $116.568 million, demonstrating improved profitability.
• Operating Income: $56.439 million, slightly down from $58.011 million, suggesting stable operational performance.
• Net Income: $39.678 million, compared to $35.439 million in the prior year, showing a positive trend in net earnings.
• Basic earnings per share: $1.13, up from $1.05, indicating increased earnings per share for shareholders.
• Diluted earnings per share: $1.11, compared to $0.99, reflecting enhanced diluted earnings per share.

Business Highlights

• Revenue Segments: Integer Holdings Corporation reported sales of $467.7 million for the three months ended September 26, 2025, and $1,381.6 million for the nine months ended September 26, 2025. The sales were primarily driven by the cardiac rhythm management, neuromodulation, and cardio and vascular markets.
• Geographical Performance: The company experienced significant foreign currency translation gains, particularly due to the strengthening of the Euro against the U.S. Dollar, which contributed to a comprehensive income of $129.9 million for the nine months ended September 26, 2025.
• New Product Launches: Integer Holdings Corporation expanded its service offerings through the acquisitions of Precision Coating LLC and VSi Parylene, which specialize in high-value surface coating technology platforms and parylene coating solutions, respectively. These acquisitions are expected to enhance the company's capabilities in providing innovative, high-quality products and solutions.
• New Production Launches: The acquisition of Precision Coating LLC and VSi Parylene included additional facilities in the New England area and Costa Rica, which are expected to support the company's growth and operational efficiency.
• Future Outlook: The company is focused on increasing its service offerings and capabilities through strategic acquisitions, which are expected to better meet customers' evolving needs and enhance the company's competitive position in the medical device market.

SEC Filing: Integer Holdings Corp [ ITGR ] - 10-Q - Oct. 23, 2025